Literature DB >> 17255097

Crystal structure of the p38 alpha-MAPKAP kinase 2 heterodimer.

Ernst ter Haar1, Prakash Prabhakar, Prakash Prabakhar, Xun Liu, Christopher Lepre.   

Abstract

The p38 signaling pathway is activated in response to cell stress and induces production of proinflammatory cytokines. P38alpha is phosphorylated and activated in response to cell stress by MKK3 and MKK6 and in turn phosphorylates a number of substrates, including MAPKAP kinase 2 (MK2). We have determined the crystal structure of the unphosphorylated p38alpha-MK2 heterodimer. The C-terminal regulatory domain of MK2 binds in the docking groove of p38alpha, and the ATP-binding sites of both kinases are at the heterodimer interface. The conformation suggests an extra mechanism in addition to the regulation of the p38alpha and MK2 phosphorylation states that prevents phosphorylation of substrates in the absence of cell stress. Addition of constitutively active MKK6-DD results in rapid phosphorylation of the p38alpha-MK2 heterodimer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255097     DOI: 10.1074/jbc.M611165200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Targeting diverse signaling interaction sites allows the rapid generation of bivalent kinase inhibitors.

Authors:  Zachary B Hill; B Gayani K Perera; Simeon S Andrews; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2011-12-22       Impact factor: 5.100

2.  The diterpenoid alkaloid noroxoaconitine is a Mapkap kinase 5 (MK5/PRAK) inhibitor.

Authors:  Sergiy Kostenko; Mahmud Tareq Hassan Khan; Ingebrigt Sylte; Ugo Moens
Journal:  Cell Mol Life Sci       Date:  2010-07-17       Impact factor: 9.261

3.  Structural basis for the regulation of the mitogen-activated protein (MAP) kinase p38α by the dual specificity phosphatase 16 MAP kinase binding domain in solution.

Authors:  Ganesan Senthil Kumar; Heiko Zettl; Rebecca Page; Wolfgang Peti
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

Review 4.  Molecular basis of MAP kinase regulation.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Sci       Date:  2013-10-19       Impact factor: 6.725

5.  Role of MAPK kinase 6 in arthritis: distinct mechanism of action in inflammation and cytokine expression.

Authors:  Toshio Yoshizawa; Deepa Hammaker; David L Boyle; Maripat Corr; Richard Flavell; Roger Davis; Georg Schett; Gary S Firestein
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

6.  Allosteric enhancement of MAP kinase p38α's activity and substrate selectivity by docking interactions.

Authors:  Yuji Tokunaga; Koh Takeuchi; Hideo Takahashi; Ichio Shimada
Journal:  Nat Struct Mol Biol       Date:  2014-07-20       Impact factor: 15.369

7.  Docking interactions of hematopoietic tyrosine phosphatase with MAP kinases ERK2 and p38α.

Authors:  Andrea Piserchio; Dana M Francis; Dorothy Koveal; Kevin N Dalby; Rebecca Page; Wolfgang Peti; Ranajeet Ghose
Journal:  Biochemistry       Date:  2012-10-05       Impact factor: 3.162

Review 8.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

9.  High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligand.

Authors:  Robert Cheng; Brunella Felicetti; Shilpa Palan; Ian Toogood-Johnson; Christoph Scheich; John Barker; Mark Whittaker; Thomas Hesterkamp
Journal:  Protein Sci       Date:  2010-01       Impact factor: 6.725

10.  Label transfer reagents to probe p38 MAPK binding partners.

Authors:  Simeon S Andrews; Zachary B Hill; B Gayani K Perera; Dustin J Maly
Journal:  Chembiochem       Date:  2013-01-14       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.